Related references
Note: Only part of the references are listed.Response to Mechanism of Action of APOL1 in Renal Allograft Survival (and Native CKD) Remains Unclear
A. M. Reeves-Daniel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The APOL1 Gene and Allograft Survival after Kidney Transplantation
A. M. Reeves-Daniel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
Robert S. Rosenson et al.
CLINICAL CHEMISTRY (2011)
Is Collapsing C1q Nephropathy Another MYH9-Associated Kidney Disease? A Case Report
Amber M. Reeves-Daniel et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
The Spectrum of MYH9-Associated Nephropathy
Meredith A. Bostrom et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Lipotoxicity in Diabetic Nephropathy: The Potential Role of Fatty Acid Oxidation
Mariana Murea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Essential hypertension and risk of nephropathy: a reappraisal
Mariana Murea et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene
Shay Tzur et al.
HUMAN GENETICS (2010)
Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15
George W. Nelson et al.
HUMAN MOLECULAR GENETICS (2010)
Apolipoprotein M expression increases the size of nascent preβ HDL formed by ATP binding cassette transporter A1
Anny Mulya et al.
JOURNAL OF LIPID RESEARCH (2010)
The Apolipoprotein L1 (APOL1) Gene and Nondiabetic Nephropathy in African Americans
Barry I. Freedman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Lawrence J. Appel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Giulio Genovese et al.
SCIENCE (2010)
Polymorphisms in the Nonmuscle Myosin Heavy Chain 9 Gene (MYH9) Are Associated with Albuminuria in Hypertensive African Americans: The HyperGEN Study
Barry I. Freedman et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans
Barry I. Freedman et al.
KIDNEY INTERNATIONAL (2009)
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD
Barry I. Freedman et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans
Lawrence J. Appel et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease
Keith L. Keene et al.
HUMAN GENETICS (2008)
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
W. H. Linda Kao et al.
NATURE GENETICS (2008)
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
Jeffrey B. Kopp et al.
NATURE GENETICS (2008)
Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome
Lewis H. Kuller et al.
ATHEROSCLEROSIS (2007)
An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma
Olof Axler et al.
JOURNAL OF LIPID RESEARCH (2007)
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
Elias J. Jeyarajah et al.
CLINICS IN LABORATORY MEDICINE (2006)
Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation
I Miljkovic-Gacic et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I
JM Timmins et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 Diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study
SS Soedamah-Muthu et al.
DIABETOLOGIA (2003)
Hypertensive nephrosclerosis in African Americans versus Caucasians
C Marcantoni et al.
KIDNEY INTERNATIONAL (2002)
Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial
JD Otvos et al.
ATHEROSCLEROSIS (2002)
The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein
N Settasatian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
